致命 发表于 2025-3-23 13:03:51

Submitted on: 17 October 1999.
Revised on: 20 January 2000.
Accepted on: 08 February 2000.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

离开真充足 发表于 2025-3-23 14:21:41

http://reply.papertrans.cn/1/47/4698/4698-12.png

纠缠 发表于 2025-3-23 18:04:16

http://reply.papertrans.cn/1/47/4698/4698-13.png

Lobotomy 发表于 2025-3-24 00:59:30

Submitted on: 13 November 2000.
Revised on: 19 February 2001.
Accepted on: 30 March 2001.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

ectropion 发表于 2025-3-24 03:46:18

Submitted on: 24 August 2009.
Revised on: 24 October 2009.
Accepted on: 25 November 2009.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

意外 发表于 2025-3-24 07:53:32

http://reply.papertrans.cn/1/47/4698/4698-16.png

nominal 发表于 2025-3-24 13:32:02

Submitted on: 28 April 2016.
Revised on: 04 August 2016.
Accepted on: 16 September 2016.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

消耗 发表于 2025-3-24 18:02:35

http://reply.papertrans.cn/1/47/4698/4698-18.png

atrophy 发表于 2025-3-24 20:08:59

http://reply.papertrans.cn/1/47/4698/4698-19.png

elastic 发表于 2025-3-25 02:36:09

Submitted on: 27 February 2024.
Revised on: 05 June 2024.
Accepted on: 28 July 2024.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY
页: 1 [2] 3 4
查看完整版本: SCIE期刊CANCER IMMUNOLOGY IMMUNOTHERAPY 2024/2025影响因子:4.605 (CANCER IMMUNOL IMMUN) (0340-7004). (IMMUNOLOGY)(免疫学)Science